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ABSTRACT
International Journal of Exercise Science 11(3): 1136-1144, 2018. The purpose was to determine if the
Alu-insertion (I)/deletion (D) polymorphism of the tissue plasminogen activator (tPA) gene influences the tPA
response to maximal exercise. Fifty male subjects (age = 23.6 ± 4.7 yrs) completed a maximal treadmill exercise test.
Blood samples were drawn before and immediately after exercise for determination of plasma tPA antigen and
activity. Isolated DNA was amplified via polymerase chain reaction, electrophoresed, and visually amplified to
determine tPA genotype. Subjects were classified as possessing the D allele (D) (n = 28) or being homozygous for
the I allele (I) (n = 22). Differences in tPA antigen and activity were assessed using a two-factor (genotype and time)
repeated measures analysis of variance. There were significant main effects for time for tPA antigen and activity (p
< 0.05), but no main effect for genotype. Furthermore, there was no genotype x time interaction due to a similar
increase in tPA antigen in the D group (pre-exercise = 5.83 + 2.39 ng/ml, post-exercise = 21.88 + 7.38 ng/ml) and
the I group (pre-exercise = 5.61 + 2.82 ng/ml, post-exercise = 19.05 + 7.67 ng/ml) and a similar increase in tPA
activity in the D group (pre-exercise = 0.39  0.19 IU/ml, post-exercise = 9.73  4.22 IU/ml) and I group (pre-exercise
= 0.45  0.29 IU/ml, post-exercise = 9.76  5.50 IU/ml). The I/D polymorphism of the tPA gene does not influence
the tPA antigen nor tPA activity responses to maximal exercise in healthy, young, sedentary males.
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INTRODUCTION
Cardiovascular disease (CVD) can ultimately manifest itself as one of several acute events,
including stroke and myocardial infarction (MI). Typically, hemorrhage or ulceration of
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atherosclerotic plaque initiates an acute ischemic event. This result of a clot formation occurs
inside the ulcerated plaque, occluding the blood vessel. However, plaque ruptures have been
observed on autopsy in individuals without history of ischemic events (4, 16). This suggests that
altered hemostasis, in addition to plaque rupture, is necessary for occlusive clot formation. In
fact, decreased fibrinolysis, the ability to lyse inappropriate or excessive clots, is a risk factor for
cardiovascular events (e.g. ischemic events, mortality, and presence of CVD) (3, 6, 10, 13, 17, 21,
24).
Although regular physical activity is an important part of CVD prevention and rehabilitation,
acute exercise can transiently increase the risk of triggering an acute event (14, 20, 22, 25).
Mittleman et al. (14) analyzed responses from 1228 patients who were interviewed an average
of four days following their MI. Heavy exertion (defined as ≥6 METS) within an hour of their
MI were reported in 4.4 percent of the patients. Additionally, of the 48.5 percent of 849 patients
in a Multicenter Investigation of Limitation of Infarct Size study where MI triggers could be
identified, 14.1 percent were due to moderate physical activity (25). Further evidence (22) from
133 men following cardiac arrest indicate the risk of cardiac arrest being highest during exercise,
particularly in those who are sedentary in nature. Ragosta et al. (20) concluded that individuals
who died during or immediately after exercise was mainly due to atherosclerosis. It was also
concluded that death during exercise in asymptomatic subjects is rare.
This increased risk of a cardiac event may be related to an altered coagulative and/or fibrinolytic
response to acute exercise. Evidence illustrates that MIs resulting from physical stress are more
likely to occur due to an occlusive thrombus compared to infarctions triggered by other causes
(5). While the fibrinolytic response to physical exercise is clinically important, the mechanism(s)
that determine the magnitude of this response is(are) not well established. Considering the
direct role plasminogen has in lysing arterial thromboses, investigating factors that affect
plasminogen in warranted.
The main enzyme of the fibrinolytic system is tissue plasminogen activator (tPA), which
catalyzes the conversion of plasminogen to plasmin and subsequently dissolves fibrin into fibrin
dimer proteins. It is possible there is considerable genetic influence on the tPA response to
exercise, as the release of endothelial tPA is regulated at the level of transcription once the initial
endothelial stores are exhausted (11). For example, an Alu-insertion (I)/deletion (D)
polymorphism of the tPA gene is associated with variability in the release rate of tPA from the
vascular endothelial cells in the forearm both at rest (9, 12) and in response to a mental stress
test (9). These reported differences in tPA release did not result in different plasma tPA activity
or antigen across genotypes. It is therefore reasonable to believe that the clearance of tPA is large
enough under the conditions reported (9, 12) to prohibit differences in plasma tPA activity or
antigen.
Exercise causes a dramatic increase in tPA release, resulting in a ~5-fold increase in tPA antigen
and a ~380-fold increase in tPA activity (2). It is then worth considering that tPA genotype
influences the tPA antigen and activity response to acute, maximal exercise. This, even despite
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the lack of influence on resting tPA antigen or activity. Therefore, the purpose of this study was
to evaluate the Alu-insertion/deletion polymorphism of the tPA gene to determine if an
association exists between this polymorphism and the tPA response to acute, maximal exercise.
METHODS
Participants
Fifty non-smoking, sedentary apparently healthy males participated in this study. Forty-seven
subjects were Caucasian, two were Hispanic, and one was African American. To reduce the
potential for confounding by factors that impact fibrinolysis, subjects were less than 40 years of
age, not taking any medications, and apparently free from known cardiovascular and/or
metabolic disease, including diabetes. Written informed consent was obtained from all subjects
prior to testing. This research was approved by the University Committee on Research
Involving Human Subjects (UCRIHS).
Table 1. Participant characteristics
Height (cm)
Weight (kg)
Age (years)
D allele (n=28)
181.4 ± 7.7
82.8 ± 11.7
23.7 ± 4.6
I/I (n=22)
179.9 ± 6.7
86.2 ± 16.0
23.5 ± 4.8
Demographic values are expressed as mean ± standard deviation for tPA D allele (containing the D allele as either
DD or ID), and I/I (homozygous for the I allele). cm = centimeters, kg = kilograms

Protocol
Treadmill test: all testing was conducted in the morning between 0700 and 1000 hours to
minimize diurnal variation in fibrinolysis (1). To minimize postural changes in tPA (29), subjects
assumed a semi-recumbent position prior to exercise for 30 minutes followed by collection of a
venous blood sample. Subjects then completed a maximal, incremental treadmill exercise test,
which began at a 0.0% incline and a speed of 2.5 mph and increased at a rate of 0.5 mph each
minute until 6 mph was achieved. At this point, elevation increased at a rate of 3% per minute
until subjects reached volitional exhaustion. Heart rate (HR) was measured every minute using
telemetry (Polar Vantage; Gays Mills, WI). Oxygen uptake (VO 2) was measured continuously
using a Sensormedics 2900 metabolic measurement cart (Sensomedics Inc; Yorba Linda, CA).
The highest minute average of VO2 achieved throughout the test was defined as the subject's
maximal oxygen uptake (VO2max). To ensure that a maximal effort had been given, subjects were
required to achieve at least two of the following criteria: 1) achievement of 90% age-predicted
maximal heart rate (HRmax), 2) maximal respiratory exchange ratio (RER) > 1.15, and 3) maximal
blood lactate concentration ([La-]) > 8.00 mmol/L. Blood samples for the determination of blood
lactate (YSI Inc, Yellow Springs, OH), hematocrit, and tPA were collected immediately before
the treadmill exercise and immediately post-exercise (2). A single blood sample was used for the
determination of blood lactate.
Blood sampling: venous samples were obtained with the subjects in a semi-recumbent position.
At each time point (pre-exercise, post-exercise), 5 ml of venous blood was drawn into an EDTA
tube (Vacutainer; Franklin Lakes, NJ) and 5 ml of blood was drawn into a tube containing an
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acidified citrate solution (Biopool International; Ventura, CA). Five hundred µl of whole blood
from the EDTA tube was used for DNA extraction and determination of hematocrits. Blood
collected in acidified citrate was immediately spun at 10,000 rpm for 20 min at 4C to obtain
platelet-poor plasma, which was stored at -80C until assayed. Cooper et al. (2) demonstrated
that tPA antigen and activity increases following a maximal treadmill test remained elevated
only two minutes post-test. Within the fourth minute, post-test values decreased significantly
from immediately post-test values. Therefore, a single sample was collected on our participants
immediately post-test for analysis.
Blood assays: both tPA antigen and activity were measured to represent total tPA, by tPA
antigen, and free tPA represented by tPA activity. An enzyme-linked immunosorbancy assay
(ELISA) (American Diagnostica Inc.; Greenwich, CT) was used to measure tPA antigen. An
amidolytic activity assay (Biopool International; Ventura, CA) was used to measure tPA activity.
All samples were assayed in duplicate. Intra-assay coefficients of variation were 4.0% and 5.0%
for tPA antigen and tPA activity, respectively. Inter-assay coefficients of variation for tPA
antigen and tPA activity were 5.7%and 5.8%, respectively. Post-exercise tPA activities and
antigens were corrected for plasma volume changes, which were calculated using the difference
between pre and post-exercise hematocrit (26).
Determination of genotypes: DNA was isolated from whole blood using a QIAamp® DNA
Blood Mini Kit (Qiagen, Valencia, CA). DNA was amplified by polymerase chain reaction (PCR)
using oligonucleotide forward and reverse primers of the polymorphic region for the tPA
polymorphism 5'-TCCGTAACAGGACAGCTCA-3' and 5'-ACCGTGGCTTCAGTCATGGA-3',
respectively. To determine validity of classification of homozygous D subjects, we performed a
second PCR to determine the presence, or absence, of an insertion allele. This was done using
an insertion specific primer (5`-GATCACGAGGTCAGGAGAT-3`) for amplification. The PCR
was performed in a final volume of 50 l containing the following: 300 ng of genomic DNA; 12
pmol of each primer; 1.5 mmol/L MgCl2; 200 M dATP, dGTP, dCTP, dTTP; 1x reaction buffer;
and 0.25 U Taq polymerase. The thermocycling procedure (Gene Amp, PCR System 2700,
Applied Biosystems, Foster City, CA) consisted of 10 minutes at 94C, 32 cycles of 1 minute at
93C, 1 minute at 64C, and 100 seconds at 72C. The final step was extended for seven minutes.
The insertion specific PCR used the same reverse primer with the addition of the insertion
specific primer and a lower annealing temperature of 60C.
Amplified DNA was
electrophoresed in a 1% agarose gel stained with ethidium bromide. The products were
detected with UV light to determine genotype for tPA. Because of the relatively low frequency
of the homozygous D genotype (9, 23), and because previous data suggest that having the D
allele can result in decreased resting tPA release (9), the heterozygous subjects and subjects
homozygous for the D allele were combined into one group (D allele). Subjects classified as
homozygous for the I allele were classified into another group (I/I).
Statistical Analysis
Differences in tPA antigen, tPA activity, and blood lactate concentrations were assessed using
repeated-measures analysis of variance with genotype (D allele, I/I) as the between-subjects
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factor, and exercise time (pre-exercise, post-exercise) as the within-subjects factor. Differences
in height, weight, age, VO2max, HRmax, respiratory exchange ratio (RER), and blood lactate
between groups were assessed using analysis of variance. Post-hoc tests were performed using
the Tukey HSD test (JMP version 3, Cary, NC). A priori significance level was set at p < 0.05 for
all statistical tests.
RESULTS
Descriptive data for both genotype groups are listed in Table 1. There were no statistical
differences between groups for height, weight, or age. Analysis for group differences for
maximal heart rate, VO2 max, RER, and Peak Blood [La-] showed no significant differences
between groups for these variables (Table 2).
Table 2. Results from the treadmill tests
HRmax (bpm)

VO2max (ml/kg/min)

RER

Blood [La-] (mmol/L)

Group D (n=28)
195 ± 9
47.10 ± 7.10
1.21 ± 0.05
9.447 ± 2.140
Group I (n=22)
194 ± 12
48.60 ± 7.67
1.18 ± 0.08
8.834 ± 2.033
Values are expressed as mean ± standard deviation for tPA Group D (containing the D allele as either DD or ID),
and Group I (homozygous for the I allele). bpm = beats per minute, ml = milliliters, kg = kilograms, min = minute,
RER = respiratory exchange ratio, La- = lactate, mmol/L = millimoles per Liter

Pre-exercise and post-exercise tPA antigen and tPA activity for both the D allele group and the
I/I group are displayed in Figure 1. There were main effects for time for tPA antigen and activity
(p < 0.05). There was no significant main effect for genotype for tPA antigen or tPA activity.
Furthermore, there was no genotype x time interaction due to a similar increase in tPA antigen
in the D group (pre-exercise = 5.83  2.39 ng/ml, post-exercise = 21.88  7.38 ng/ml) and the I
group (pre-exercise = 5.61  2.82 ng/ml, post-exercise = 19.05  7.67 ng/ml) and a similar
increase in tPA activity in the D group (pre-exercise = 0.39  0.19 IU/ml, post-exercise = 9.73 
4.22 IU/ml) and I group (pre-exercise = 0.45  0.29 IU/ml, post-exercise = 9.76  5.50 IU/ml).

Figure 1. Pre and post-exercise values for A.) tPA antigen (ng/ml), and B.) tPA activity (IU/ml). D allele (containing
the D allele as either DD or ID), and I/I (homozygous for the I allele).
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DISCUSSION
The major finding of the present study is that individuals possessing at least one D allele of the
tPA gene do not differ in tPA antigen or tPA activity response to maximal exercise from
individuals that are homozygous I. Previous data showed no association between I/D
polymorphism and resting plasma tPA antigen (8, 27) nor resting plasma tPA activity (27).
Similarly, resting tPA antigen and activity were similar across groups in this study. Although
previous data suggests a higher resting tPA release rate in individuals with the I/I genotype (9,
12), tPA release did not translate into significant differences in tPA antigen or activity. This lack
of tPA difference is presumably due to the release of tPA being balanced by inactivation and
increased clearance. However, exercise results in rather large increases in tPA release, which
was hypothesized to result in a higher post-exercise plasma tPA in individuals homozygous for
the I allele. However, these data suggest an identical exercise response for individuals
homozygous for the I allele and individuals possessing the D allele.
Our results suggest the increased release of tPA occurring in subjects homozygous for the I allele
is not biologically significant since we found no difference between genotype groups in plasma
tPA. Another possibility is increased tPA release during exercise occurs from other sources, and
the I/D polymorphism is only associated with differences in endothelial tPA release. Wang et
al. (28) observed that tPA is also synthesized and released from sympathetic nerve terminals in
the rat. Furthermore, skeletal muscle has been identified as a source of tPA synthesis (7).
Therefore, the D allele of the tPA I/D polymorphism may be associated with a decreased
endothelial cell release of tPA at rest, but this difference may be offset by tPA release from other
sources. This possibility is speculative and future research should ascertain the role of this
polymorphism on tPA release from different sites in response to acute exercise.
It is also possible the tPA I/D polymorphism did not influence tPA release in our subjects.
However, Jern et al. (9) reported greater release of tPA in homozygous I subjects at rest in 51
apparently healthy, non-obese, nonsmoking, male subjects. Considering subjects in the present
study were very similar to those studied by Jern et al. (9), it is likely that the subjects in the
current study in the I group also had a higher resting release rate of tPA. However, unlike the
Jern et al. (9) article this cannot be proven with the present data, as we did not measure release
of tPA. Even so, Jern et al. (9) found that there was no correlation between the net tPA release
rate and the arterial plasma level of either tPA antigen or tPA activity. Data from the present
study suggest that, even if the release of tPA during exercise is higher in subjects homozygous
for the I allele, it is not associated with plasma tPA levels.
If the regulation of tPA levels is not explained through the I/D polymorphism, other
mechanisms must be explored. Moore et al. (15) found that plasma tPA levels are influenced by
the angiotensin-converting enzyme (ACE) I/D and plasminogen activator inhibitor-1 (PAI-1)
4G/5G polymorphism. Once tPA is bound to PAI-1 it has a slower clearance rate, which can
elevate tPA antigen levels, and increase tPA release. Pretorius et al. (19) demonstrated that ACE
inhibition increases constitutive endothelial tPA release through endogenous bradykinin. It is
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also possible that acute tPA responses by mechanisms affecting the release of stored tPA and
regulation of tPA may only affect restocking of tPA stores and not the release and/or circulating
levels (19).
Giri et al. (5) observed that myocardial infarctions resulting from physical exertion were more
frequently due to occlusive thrombus formation than infarctions resulting from other triggers.
Specifically, all 64 out of the 64 of the patients with an exertion-related acute MI were reported
to having an intracoronary thrombus ≥2 mm. This compared to only 35 out of 576 patinets that
experienced a non-exertion-related acute MI, a reported p-value of 0.001. Thus, coagulation
and/or fibrinolytic responses to physical stress may have important clinical significance. van
der Bom et al. (27) noted an increased risk MI in individuals with the I/I genotype. This finding
is in contrast to the study by Jern et al. (9) who found no association between genotype and risk
of MI. Findings by Hooper et al. (8) showed a nonsignificant positive association between the
D allele and MI in African American adults. Regardless, results from the present study suggest
that any association between the tPA I/D polymorphism and risk of MI is not likely due to a
suppressed tPA response to exercise in subjects with the D allele. The subjects in the present
study were all sedentary males and predominantly Caucasian. Therefore, the results cannot be
generalized across genders, physical training status, or race. Maximal aerobic exercise was
utilized in the current study to elicit a tPA antigen and tPA activity response, a known effect on
increasing plasma tPA antigen and activity (2, 18). While acute, maximally intense exercise did
not elicit a difference in the change in plasma levels of tPA antigen nor tPA antigen between
groups, future research should determine the effects of varying levels of duration of physical
activity on tPA response between the tPA I/D genotypes.
In conclusion, the I/D polymorphism of the tPA gene does not influence the tPA antigen nor
the tPA activity responses to maximal exercise in healthy, young, sedentary males. Future
studies should evaluate mechanisms of tPA release, including the influence of other
polymorphisms on the tPA response to exercise.
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